Infleqtion (INFQ) Registration filing summary

Company overview and business model

• Develops and commercializes quantum technology products, including quantum sensing, computing, and software, with a vertically integrated, full-stack platform built on neutral atom architecture.

• Products address sectors such as defense, AI, energy, space, materials discovery, and cybersecurity, with real-world deployments and a focus on government and enterprise customers.

• Revenue streams include direct product sales, quantum computing as a service, software licensing, and government/commercial contracts.

• Strategic partnerships with defense primes, technology firms, and research institutions support market access and product development.

• Business model balances near-term cash generation from sensing products and R&D contracts with long-term growth in scalable quantum systems.

Financial performance and metrics

• Revenue increased 13% to $32.5 million in 2025, driven by higher service revenue, partially offset by a decline in product revenue.

• Net loss for 2025 was $31.8 million, an improvement from a $53.8 million net loss in 2024; accumulated deficit reached $231.1 million.

• Research and development expenses rose 8% to $24.1 million in 2025, reflecting ongoing investment in technology and product development.

• Cash and cash equivalents as of December 31, 2025, were $11.9 million, with a significant liquidity boost from the business combination and PIPE financing in early 2026.

• Gross profit for 2025 was $11.8 million, with total cost of revenue at $20.7 million.

Use of proceeds and capital allocation

• Up to $119.9 million may be received from the exercise of warrants, with proceeds intended for general corporate purposes.

• No proceeds will be received from the resale of shares or warrants by selling securityholders.

• Recent capital raises include $126.5 million PIPE financing and $100 million Series C preferred stock, supporting scaling of quantum platforms and general corporate needs.

• Ongoing investments in R&D, field demonstration units, and strategic acquisitions to advance the technology roadmap.